|
Status |
Public on Dec 31, 2022 |
Title |
An epigenetic switch controls the expression of an alternative NR2F2 isoform that unleashes a pro-metastatic program in melanoma. |
Organism |
Homo sapiens |
Experiment type |
Methylation profiling by array
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
Refer to individual Series
|
Web link |
https://pubmed.ncbi.nlm.nih.gov/37015919/
|
|
|
Citation(s) |
37015919 |
Submission date |
Sep 14, 2022 |
Last update date |
Jun 02, 2023 |
Contact name |
IJC Bioinformatics |
E-mail(s) |
ijcbioinfo@carrerasresearch.org
|
Organization name |
Josep Carreras Leukemia Research Institute
|
Lab |
Bioinformatics Unit
|
Street address |
Josep Carreras Building, Ctra de Can Ruti, Camà de les Escoles, s/n
|
City |
Badalona |
State/province |
Catalonia |
ZIP/Postal code |
08916 |
Country |
Spain |
|
|
Platforms (2) |
GPL13534 |
Illumina HumanMethylation450 BeadChip (HumanMethylation450_15017482) |
GPL21145 |
Infinium MethylationEPIC |
|
Samples (12)
|
|
This SuperSeries is composed of the following SubSeries: |
GSE213382 |
An epigenetic switch controls the expression of an alternative NR2F2 isoform that unleashes a pro-metastatic program in melanoma [450K] |
GSE213390 |
An epigenetic switch controls the expression of an alternative NR2F2 isoform that unleashes a pro-metastatic program in melanoma [EPIC] |
|
Relations |
BioProject |
PRJNA880835 |